Safety Profile and Adverse Events Associated with Repeated Epidural Steroid Injections in Chronic Low Back Pain: A Retrospective Study

Background: Chronic low back pain (CLBP) remains one of the most prevalent causes of disability around the world. Epidural steroid injections (ESIs) are commonly employed to alleviate persistent symptoms, and multiple injections are sometimes performed when pain recurs or persists. Nonetheless, there are ongoing concerns regarding the safety of repeated ESIs, including possible infections, neurologic compromise, and systemic steroid-related effects. Methods: In this retrospective investigation, patient records from a tertiary care hospital were reviewed to identify adults with CLBP who underwent at least two lumbar ESIs within a single year. We noted demographic data, the total number of injections, the time between injections, and both immediate (e.g., vasovagal responses) and delayed (e.g., infections, neurologic deficits) adverse events. Descriptive statistics were used to characterize the patient population, and we compared the frequency and nature of adverse events relative to the number of injections. Results: A total of 250 patients (mean age 52.4 ± 11.2 years, 62% female) met the inclusion criteria. On average, participants received 2.7 ± 0.4 injections over the study period. Forty-eight patients (19.2%) experienced at least one adverse event, of which 67% were mild and self-limiting (e.g., short-term headache, localized injection-site discomfort). More severe complications—such as infection or transient neurological deficits—occurred in 2.8% of the cohort, predominantly among those who underwent more than three injections. No irreversible neurologic harm or life-threatening infections were identified. Conclusion: These findings indicate that repeated ESIs for CLBP can generally be performed with an acceptable safety margin in carefully selected patients. However, the likelihood of adverse events appears to increase with the total number of injections. Clinicians must balance the analgesic benefits of repeated ESIs against potential complications, especially in individuals requiring multiple procedures.

Authors

Publication Details

Journal
Journal of Neonatal Surgery
Published
2025-03-21
DOI
https://doi.org/10.52783/jns.v14.2440
Primary Topic
Spine and Intervertebral Disc Pathology
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Safety Profile and Adverse Events Associated with Repeated Epidural Steroid Injections in Chronic Low Back Pain: A Retrospective Study

Pulkit Prakash, Pramod Kumar Sharma, Shweta Verma
1 links
Journal of Neonatal Surgery
Spine and Intervertebral Disc Pathology
article

Safety Profile and Adverse Events Associated with Repeated Epidural Steroid Injections in Chronic Low Back Pain: A Retrospective Study

Pulkit Prakash, Pramod Kumar Sharma, Shweta Verma
article en

Abstract

Background: Chronic low back pain (CLBP) remains one of the most prevalent causes of disability around the world. Epidural steroid injections (ESIs) are commonly employed to alleviate persistent symptoms, and multiple injections are sometimes performed when pain recurs or persists. Nonetheless, there are ongoing concerns regarding the safety of repeated ESIs, including possible infections, neurologic compromise, and systemic steroid-related effects. Methods: In this retrospective investigation, patient records from a tertiary care hospital were reviewed to identify adults with CLBP who underwent at least two lumbar ESIs within a single year. We noted demographic data, the total number of injections, the time between injections, and both immediate (e.g., vasovagal responses) and delayed (e.g., infections, neurologic deficits) adverse events. Descriptive statistics were used to characterize the patient population, and we compared the frequency and nature of adverse events relative to the number of injections. Results: A total of 250 patients (mean age 52.4 ± 11.2 years, 62% female) met the inclusion criteria. On average, participants received 2.7 ± 0.4 injections over the study period. Forty-eight patients (19.2%) experienced at least one adverse event, of which 67% were mild and self-limiting (e.g., short-term headache, localized injection-site discomfort). More severe complications—such as infection or transient neurological deficits—occurred in 2.8% of the cohort, predominantly among those who underwent more than three injections. No irreversible neurologic harm or life-threatening infections were identified. Conclusion: These findings indicate that repeated ESIs for CLBP can generally be performed with an acceptable safety margin in carefully selected patients. However, the likelihood of adverse events appears to increase with the total number of injections. Clinicians must balance the analgesic benefits of repeated ESIs against potential complications, especially in individuals requiring multiple procedures.

Journal of Neonatal SurgeryVol. 14(7S)
Openalex Percentile: Top 91%
Spine and Intervertebral Disc Pathology
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.